Therapeutic effects of pentoxifylline on diabetic heart tissue via NOS

Creative Commons License

Karabulut D., Ulusoy H. B., Kaymak E., Sonmez M. F.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.5, pp.310-315, 2016 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.5152/akd.2015.6252
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.310-315
  • Keywords: diabetes mellitus, eNOS, iNOS, nNOS, heart, rat, NITRIC-OXIDE SYNTHASE, MITOCHONDRIAL OXIDATIVE STRESS, LEFT-VENTRICULAR FUNCTION, VITAMIN-C, ENOS EXPRESSION, TNF-ALPHA, MELATONIN, ATTENUATION, SUPPRESSION, APOPTOSIS
  • Yozgat Bozok University Affiliated: No

Abstract

Objective: Diabetes mellitus causes a decrease in cardiac output, arterial blood pressure, and heart rate. In this study, we aimed to investigate, at the molecular level, the effect of nitric oxide synthase (NOS) on heart pathology in type 1 diabetes and look at the therapeutic effect of pentoxifylline on this pathology.